Yongxin Han
6PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 09, 2026
From KRASG12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design.Xiaoshen Ma, David L Sloman, Timothy J Henderson
|Jun 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor.Xiaoshen Ma, David L Sloman, Ruchia Duggal
|Apr 08, 2024
The Pan-RAF-MEK Nondegrading Molecular Glue NST-628 Is a Potent and Brain-Penetrant Inhibitor of the RAS-MAPK Pathway with Activity across Diverse RAS- and RAF-Driven Cancers.Meagan B Ryan, Bradley Quade, Natasha Schenk
|Aug 16, 2023
Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric Modulator.Michael T Rudd, Peter J Manley, Barbara Hanney
|Mar 03, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.Derun Li, David L Sloman, Abdelghani Achab
|Sep 17, 2021
Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors.Brett Hopkins, Hongjun Zhang, Indu Bharathan
Pageof 1
Frequent Collaborators
3 joint publications
David L Sloman
2 joint publications
Hongjun Zhang
2 joint publications
Qinglin Pu
2 joint publications
Theodore A Martinot
2 joint publications
Xavier Fradera
2 joint publications
Charles A Lesburg
2 joint publications
David Jonathan Bennett
2 joint publications
Erik V Munsell
2 joint publications
Thomas W Lyons
2 joint publications
Xiaoshen Ma
